about imatinib anticancer tyrosine- kinase inhibitor first generation. mechanism of action of imatinib imatinib is an inhibitor of multiple tyrosine kinases including kit abl and pdgfr( platelet-derived growth factor receptor) and inhibit phosphorelation.
